Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
NEWSLETTER  |  PRINT VERSION
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine > News > Night-shift work and breast cancer risk: potential biological mechanism identified
  • News

Night-shift work and breast cancer risk: potential biological mechanism identified

  • 6 July 2020
  • Adriana Albini
Night-shift work and breast cancer risk: potential biological mechanism identified
Total
0
Shares
0
0
0
0
0

Is night-shift work a risk factor for breast cancer? Experimental research just published in Nature Communications gives the molecular basis for asserting that it may well be.

Researchers at Paris-Saclay University, with colleagues from Inserm and Inrae, studied the association between night work and increased tumour aggressiveness. They created a simulated jet-lag situation for mice that reproduced a change in the rhythm between day and night. The collaborative teams observed how disturbances in the circadian rhythm had an impact on breast cancer stem cells and the development of breast tumours. In particular they detected an increased spread of cancer cells and the formation of metastases. They speculated that this is related to increased inflammation. The higher expression of chemokines in circadian-disturbed mice induced infiltration of pro-inflammatory myeloid cells in the microenvironment, causing suppression of adaptive immunity.

Several mechanisms have been postulated before to explain an association between night work and breast cancer, with inhibition of the hormone melatonin by the use of artificial light at night widely seen as the most likely (eg Hansen J, Curr Environ Health Rep 2017).
In the study published in Nature Communications, the use of a chemokine receptor inhibitory drug, which influences the neutrophils and myeloid cells, limited the effect on tumour progression, confirming a role for inflammation.

The topic is controversial. In June 2019, a working group convened by the International Agency for Research on Cancer (IARC) concluded that “night shift work” is “probably carcinogenic to humans” (a Group 2A carcinogen). A paper by the Department of Hygiene and Epidemiology of the Medical University of Łódź, Poland, published the following January (Int J Environ Res Public Health, 2020), found a significantly higher risk of cancer among people working at night. However, other studies have found little or no correlation at all. Exactly a year ago (7 July 2020) Lancet Oncology reported a new cohort study concluding that night shift work does not increase the risk of breast cancer.

The evidence from the Nature Communications study provides important additional evidence to support the proposition that such a link does exist, and about the molecular mechanism involved.

Risk factors for breast cancer are multiple: hereditary (mostly BRCA1 and 2 genes), behavioural (smoke, pollution, parity, lactation) or related to poor nutrition or alcohol consumption. Hormonal factors play an obvious role. There is still a long way to go to understand the influence of time-shifts and work-related stress.

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • breast cancer
  • circadian rhythms
  • risk factors
  • shift work
Adriana Albini

Previous Article
  • Articles
  • Featured

Guiding career paths from trainee doctor to oncology leader

  • 6 July 2020
  • Anna Wagstaff
View Post
Next Article
  • In the Hot Seat

Solange Peters: ESMO President

  • 6 July 2020
  • Editorial Staff
View Post
You May Also Like
View Post
  • News

US study suggests colorectal cancer screening should start at age 45

  • Janet Fricker
  • 25 May 2022
View Post
  • News

Multicomponent prevention strategy reduces risk of cancer

  • Janet Fricker
  • 20 May 2022
View Post
  • News

Lumpectomy as effective as mastectomy in young breast cancer patients

  • Janet Fricker
  • 13 May 2022
View Post
  • News

Multi organ chip could facilitate personalised cancer therapy 

  • Janet Fricker
  • 12 May 2022
View Post
  • News

100,000 Genomes Project pinpoints new cancer genetic culprits

  • Janet Fricker
  • 29 April 2022
View Post
  • News

IL-6 provides missing link between exercise and colon cancer protection

  • Janet Fricker
  • 28 April 2022
View Post
  • News

CAR T-cell therapy shows efficacy in solid tumours

  • Janet Fricker
  • 20 April 2022
View Post
  • News

No link between brain tumours and ‘usual’ use of mobile phones

  • Janet Fricker
  • 14 April 2022

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

search
or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • US study suggests colorectal cancer screening should start at age 45
    • 25 May 2022
  • Multicomponent prevention strategy reduces risk of cancer
    • 20 May 2022
  • Lumpectomy as effective as mastectomy in young breast cancer patients
    • 13 May 2022
  • Multi organ chip could facilitate personalised cancer therapy 
    • 12 May 2022
  • 100,000 Genomes Project pinpoints new cancer genetic culprits
    • 29 April 2022
Article
  • Cervical cancer: Rebuilding a nation’s broken trust in their screening service
    • 25 May 2022
  • What can we expect from mRNA cancer vaccines?
    • 13 May 2022
  • Sri Lanka cancer care hit by foreign currency crisis
    • 6 May 2022
Latest printed issue
Social

Would you follow us ?

Contents
  • Message from a Ukrainian oncologist: Please prioritise my patients ‒ if you don’t who will?
    • 19 April 2022
  • Pandemics, War, Reconstruction and the Duty of Medicine and Science
    • 4 April 2022
  • Crisis in the Ukraine: we can help by doing what we do best
    • 4 March 2022
MENU
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine
  • About the Magazine
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is funded by SPCC Sharing Progress in Cancer Care | Piazza Indipendenza 2, 6500 Bellinzona - Switzerland | info@spcc.net

Archivio Cancerworld

Input your search keywords and press Enter.